‘Grey’s Anatomy’ Season 14: Stars Tease ‘Drama, Drama, Drama’ With Japril & ‘Jaggie’ – Moviefone

Sarah Drew and Jesse Williams, you are killing us. "Grey's Anatomy" Season 14 is now filming, and the actress who plays April Kepner has been doing a great job sharing photos from set. Fans are loving the glimpses of their favorites, and she must've known she'd get a reaction when she shared a "Japril" photo with Jesse Williams (Jackson Avery), then followed later with a photo of the two of them with Kelly McCreary (Maggie Pierce). Jesse Williams posted his own photo of the trio, even baiting fans with a new #Jaggie 'ship name to rival #Japril.

The Season 13 finale had a lot of shockers, and -- on the relationship front -- one of them was the idea of Maggie and Jackson maybe being a thing. April even seemed to give her blessing. Fans did NOT. So when Sarah Drew posts a cute photo of the three April/Jackson/Maggie stars along with the words "drama, drama, drama..." well, she had to know it would get fans talking again. And it did. Williams did the same with his "Jaggie" tease, and it too got fans calling for Japril to rise.

Super cute pics, but yeah. The comments are filled with Japril supporters writing things like "Cant like this! Maggie and Jackson the Worst storyline ever #japrilforever."

Poor Maggie. She deserves better than this storyline, to be honest. Give Maggie her own man, Shonda!

The actors themselves get along great, as you can see in Drew's other photos with McCreary, Williams, and their co-stars:

Want more stuff like this? Like us on Facebook.

Go here to see the original:
'Grey's Anatomy' Season 14: Stars Tease 'Drama, Drama, Drama' With Japril & 'Jaggie' - Moviefone

Ecovative lays off 18 as it shifts gears toward bioengineering – Albany Times Union

Machine operators move protective packaging material, that's made from mushrooms, from molds to a cart on Tuesday, Feb. 16, 2016, at Ecovative Design in Troy, N.Y. From left are Aaron Ford, Lance Tucker and Aldwin Berry. (Cindy Schultz / Times Union) less Machine operators move protective packaging material, that's made from mushrooms, from molds to a cart on Tuesday, Feb. 16, 2016, at Ecovative Design in Troy, N.Y. From left are Aaron Ford, Lance Tucker and ... more Photo: Cindy Schultz Mayor Patrick Madden, center, holds protective packaging while production manager Katie Malysa, right, explains it's made from mushrooms on Tuesday, Feb. 16, 2016, at Ecovative Design in Troy, N.Y. At left is Andy Ross of Ross Valve. (Cindy Schultz / Times Union) less Mayor Patrick Madden, center, holds protective packaging while production manager Katie Malysa, right, explains it's made from mushrooms on Tuesday, Feb. 16, 2016, at Ecovative Design in Troy, N.Y. At left is ... more Photo: Cindy Schultz

Machine operator Lance Tucker, right, carries protective packaging material, that's made from mushrooms, on Tuesday, Feb. 16, 2016, at Ecovative Design in Troy, N.Y. (Cindy Schultz / Times Union)

Machine operator Lance Tucker, right, carries protective packaging material, that's made from mushrooms, on Tuesday, Feb. 16, 2016, at Ecovative Design in Troy, N.Y. (Cindy Schultz / Times Union)

Ecovative lays off 18 as it shifts gears toward bioengineering

Ecovative Design, the Green Island startup that makes building and packaging materials out of biodegradable mushroom material, is laying off 18 people, between 20 to 30 percent of its total staff.

The job cuts are the first major layoffs that Ecovative CEO Eben Bayer has had to do since he co-founded the company about 10 years ago while a student at Rensselaer Polytechnic Institute in Troy.

Ecovative, which recently won a $9.1 million grant from the Defense Advanced Research Projects Agency, or DARPA, is now headquartered in Green Island in 32,000 square feet of space and has a second manufacturing facility in Troy with 20,000 square feet of space.

The layoffs are associated with the cessation of two new product projects that have ended for different reasons. In one case, a commercial partner had decided not to fund a Phase II of the program.

"The projects that these folks were working on went away," Bayer told the Times Union. "We're not shutting down. We're not going away. We're not ceasing production. We're continuing to do manufacturing."

Still, Bayer said he had to let some really good employees go, and it was not easy for him or others in management to make that decision. The company employed in the neighborhood of 70 people before the layoffs occurred.

However, he said the company has to remain sustainable in the long run, one of the reasons why the company did not decide to try and subsidize the jobs without corresponding revenue.

"It's sad," Bayer said. "This was so hard."

Bayer added that he believes the teams that were laid off will become assets at other companies quickly.

"Those impacted are some of the smartest, hardworking and talented individuals I have worked with," Bayer said. "I know that their skills will be in high demand in the Capital Region."

Laid-off workers received compensation and health care packages that depended on their length of service.

The layoffs come, however, as Ecovative, a privately held company that does not reveal financial data to the public, is shifting gears in a way that may end up leading to many more hires.

One of the new product programs could also be re-launched as a spin-off company, but Bayer said it was too early to sustain it now on its own. He said both product programs were secret and the company did not publicize what they were working on.

Bayer said the company has exhausted what it can do with using native mycelium, the fungus "filaments" that grow into mushrooms, to bind together other biodegradable materials into molds.

Instead, the company has started experimenting with bioengineering mycelium to create new properties in self-growing building materials for instance mycelium that can be certain colors or have insect resistant properties. The DARPA grant is being used to create bioengineered materials that will grow temporary shelters in place.

The ideas of bioengineering these new self-growing materials are limitless, and have a much larger market potential than the company's current product line of MycoBoard and MycoFoam.

"For me, that's the next frontier," Bayer said. "I'm really excited about it."

The company is currently hiring a molecular biology technician as part of this new research and development push.

"This role will perform molecular biology techniques, strain preservation and maintenance, species cultivation, substrate preparation and mixing, maintain lab inventory, assist in scale up, prepare materials for experimentation, and perform data collection," the job posting states.

Go here to read the rest:
Ecovative lays off 18 as it shifts gears toward bioengineering - Albany Times Union

UI losing vice chancellor for research, top chemistry professor to Yale – Champaign/Urbana News-Gazette

Photo by: Provided

Peter Schiffer

Image

CHAMPAIGN The vice chancellor for research at the University of Illinois and a top chemistry professor on campus are both leaving after five years for two newly created positions at Yale.

Vice Chancellor Peter Schiffer and his wife, Professor Sharon Hammes-Schiffer, who holds one of the prestigious Swanlund endowed faculty chairs on campus, were recruited by Yale, officials at the two schools announced Thursday.

Schiffer, a Yale alumnus, will be the Ivy League school's inaugural vice provost for research, starting in October.

He will be joined at Yale in January by Hammes-Schiffer, who will be the inaugural John Gamble Kirkwood Professor of Chemistry. At the UI, she is a renowned theoretical chemist who specializes in modeling quantum mechanical processes in systems relevant to both energy and biological sciences. She was recently named to the Center for Advanced Study at Illinois, the highest honor the campus bestows.

"It's a really exciting opportunity for me and for Sharon," Schiffer said Thursday. "Yale is, like Illinois, a great research institution."

It's also a chance to be closer to their sons, Zachary and Benjamin, who are students at MIT and Princeton, respectively, he said.

Hammes-Schiffer was out of town and unavailable for comment Thursday.

Schiffer, an experimental physicist, joined the UI in 2012 as vice chancellor for research after five years as associate vice president for research and director of strategic initiatives at Penn State.

He earned his bachelor's degree in physics from Yale in 1988 and a doctorate in physics from Stanford in 1993. He then did postdoctoral work at AT&T Bell Laboratories before launching his faculty career as an assistant professor of physics at Notre Dame.

Schiffer said his job at Yale, upgraded from a deputy provost's position, will be similar to his UI post.

It was created to bring a new level of strategic attention to Yale's science and research enterprise, according to President Peter Salovey and Provost Benjamin Polak. They cited Schiffer's decade of experience in university leadership and noted his record of strategic planning, policy development and leadership in campuswide cross-disciplinary initiatives.

Schiffer's UI tenure coincided with the growth of the university's interdisciplinary research enterprise, recognized as "one of the very best in the world," with seven campus institutes, UI Chancellor Robert Jones said in a statement. Those include two new entities the Institute for Sustainability, Energy and Environment and the Interdisciplinary Health Sciences Institute, both identified as priorities in an earlier campus strategic plan.

Schiffer said he expects those research areas to continue to grow, especially with the addition of the Carle Illinois College of Medicine. In the last month, the UI has announced a new Cancer Center and a $104 million Center for Advanced Bioenergy and Bioproducts Innovation funded by the U.S. Department of Energy.

He is also proud of the improved support for researchers in the humanities and areas outside the traditional science, technology, engineering and math fields, or STEM.

"It's a great place, and I've really enjoyed working here," he said.

Hammes-Schiffer is considered one of the world's leading experts in computational studies of proton-coupled electron transfer, an important process for many chemical reactions, Department of Chemistry head Martin Gruebele said. She is a member of the National Academy of Sciences and the American Academy of Arts and Sciences.

She will continue her research and teaching this fall before leaving for Yale in January, he said.

Her "collegiality and citizenship will be missed along with the high quality of her science," he said.

Excerpt from:
UI losing vice chancellor for research, top chemistry professor to Yale - Champaign/Urbana News-Gazette

Continuity and chemistry key for Steelers offensive line | FOX Sports – FOXSports.com

LATROBE, Pa. (AP) Alejandro Villanueva was in mid-answer trying to put his new contract the one that puts the former Army Ranger-turned-NFL left tackle in charge of protecting Pittsburgh Steelers quarterback Ben Roethlisbergers blind side for the rest of the decade in perspective when Ramon Fosters distinct Tennessee drawl came crashing over the top.

Oh yes, Al! Foster said as he walked past. Pay the man! Get us new chairs in the O-line room.

Villanueva smiled and shook his head at Fosters impromptu interview bomb, though the veteran guard and elder statesman on the unit most vital to Pittsburghs chances at ending New Englands long run at the top of the AFC might have a point.

The seats in the groups meeting room are getting well worn. Call it the byproduct of the kind of stability thats a rarity in the salary cap era. The way the Steelers figure it, better to break in new furniture than new faces.

Villanuevas deal, signed minutes before the defending AFC North champions opened training camp, means Pittsburghs entire front five Villanueva at left tackle, Foster at left guard, Maurkice Pouncey at center, David DeCastro at right guard and Marcus Gilbert at right tackle are all signed through the end of the 2018 season, with all but Foster in the fold through at least 2020.

Its rare, especially in this league, DeCastro said. Guys are all under their second contracts. It doesnt really happen. You have to make it show.

It certainly did last season. Pittsburgh ripped off seven straight wins after a 4-5 start to win its second division title in three years, with the line opening gaping holes for LeVeon Bell and keeping Roethlisbergers No. 7 jersey pristine in the process. Bell averaged 139 yards rushing during the stretch, with Roethlisberger being taken down just three times.

While Roethlisberger is serious when he says hes working on a season-by-season basis at this point, there are certain factors could see him walk off into retirement later rather than sooner. Namely, staying upright nearly all the time behind a line among the best in the business.

If they play as well as theyve been playing and getting sacked 17 times in a year, that might keep me around a little longer, he said with a smile.

Compare that to the early days of the 35-year-old Roethlisbergers career, when he spent a considerable portion of his time picking himself up off the turf.

Roethlisberger was sacked an average of three times a game I his first decade. Over the last three years, that number has dropped below two. Part of it is Roethlisbergers embracing of Todd Haleys get it and get rid of it ethos, part of it is playing behind a group thats grown in lockstep and part of it is the arrival of Hall of Famer Mike Munchak as the line coach in 2014.

He brings all the pieces together, Villanueva said. Hes the one that can put in anybody and make him excel just like he did with me.

Villanueva arrived in Pittsburgh a few months after Munchak, simply looking for a chance to learn following a military career that included three tours in Afghanistan. Villanueva landed a job on the practice squad that fall. Thanks in large part to Munchaks guidance, Villanueva was starting by the end of 2015 and didnt miss a game in 2016 as the Steelers reached the AFC championship.

His rapid rise also put the thoughtful, introspective Villanueva in a tough spot. He believed hed earn a raise and Pittsburgh wanted to keep him around. The sticking point came on how much it was going to take. Forever wanting to blend in not an easy thing when youre 6-foot-9 and 320 pounds Villanueva found the attention surrounding his status embarrassing.

I didnt want to break the bank, he said. I didnt want to be compared to the top left tackles that signed a deal recently. I couldnt conceive a situation where I would hold out to get more money. It was more if the situation was fair, I wanted to be here.

And so he is, where his unique backstory blends right in a group that mixes sure things like Pouncey and DeCastro, both first-round picks, with Foster and Villanueva, undrafted success stories.

They are now all well compensated and in their primes, with the 31-year-old Foster the only one not in his 20s. Yet there are no concerns of complacency. Munchaks draining individual drills and searing wit keeping things fresh. So does chemistry and a sense of accountability. Nobody wants to be the guy who gets exposed in the film room, where Munchaks searing wit rarely misses its target.

Whenever your guy makes the play, whenever you give up a pass rush or something, its just something that sticks with you for a long time, Pouncey said.

Those moments are getting fewer and farther between. Yet nothing lasts forever. Injuries happen. Contracts end. Guys move on. The five friends who hold Roethlisbergers health, and perhaps Pittsburghs season, in their collective hands understand how unique the opportunity is.

We have to take advantage of that, DeCastro said. We have a small window to really take advantage of it and play good football.

For more NFL coverage: http://www.pro32.ap.org and http://www.twitter.com/AP-NFL

See the original post here:
Continuity and chemistry key for Steelers offensive line | FOX Sports - FOXSports.com

Anti-aging medicine group says field isn’t ‘controversial’ – FierceHealthcare

A group dedicated to the advancement of treatment for diseases associated with aging disputes what they describe as a mischaracterization that their field of medicine endorses controversial practices.

The American Academy of Anti-Aging Medicine (A4M) says there is nothing controversial about anti-aging medicine described in an article about Brenda Fitzgerald, M.D., who was recently appointed director of the Centers for Disease Control and Prevention. Fitzgerald is board-certified in anti-aging and regenerative medicine by the organization.

The article noted that some practitioners questioned the choice of Fitzgerald for the high-level government position based on her previous support for anti-aging treatments that they said were unproven and anti-scientific.

It also raised concerns that Fitzgerald partnered with Coca-Cola to run a program against child obesity when she was Georgias public health commissioner. That program focused on physical activity but didnt encourage the need to reduce soda consumption due to its high sugar content.

But Robert Hughes, spokesman for A4M, said in an email to FierceHealthcare that the characterization of anti-aging medicine is false and misleading.

While some may not yet embrace the term anti-aging medicine, there is no controversy over the need for physicians to learn how to stem the rising tide of chronic disease through prevention, lifestyle educationand incorporation of the latest scientific research to help patients live healthier, longer lives, he says. Patients want this. Physicians want this for their patients. A4M provides advanced postgraduate Continuing Medical Education (CME) and training that enables this to occur.

Hughes describes A4M as aU.S. federally registered 501(c)(3) nonprofit organization comprised of more than 26,000 members across the globe, including physicians, scientists and governmental officials, all of whom collectively represent more than 120 nations.

In its 25-year history, he says, A4M has never been the subject of any adverse legal ruling, nor ever been the target of any regulatory procedure or penalty.

We know through experience that, when practiced by trained physicians, the protocols A4M teaches can result in improved patient health. In addition, these techniques help patients avoid chronic conditions that are major drivers of the relentlessly expanding costs of healthcare, he says.

See the rest here:
Anti-aging medicine group says field isn't 'controversial' - FierceHealthcare

Protein at All 3 Meals May Help Preserve Seniors’ Strength – Sioux City Journal

THURSDAY, Aug. 3, 2017 (HealthDay News) -- Eating protein at all three daily meals, instead of just at dinner, might help seniors preserve physical strength as they age, new research suggests.

The Canadian study found that protein-rich meals evenly spread throughout the day staved off muscle decline, but did not increase mobility, in older people.

Study co-author Stephanie Chevalier said, for seniors, "The important point is to create three meal occasions with sufficient protein to stimulate muscle building and greater strength, instead of just one."

Chevalier is an assistant professor of medicine at McGill University in Montreal.

The functional decline associated with aging often leads to falls, mental impairment and loss of independence. Chevalier's team wondered if more evenly distributed protein consumption might be tied to better physical performance and a reduced rate of decline.

To find out, they tracked more than 1,700 relatively healthy Quebec men and women, aged 67 to 84, who were all enrolled in a three-year study.

The participants provided dietary information and underwent yearly hand, arm, and leg strength testing. They were also tested for mobility.

Over the three years, the researchers found that both men and women saw their overall physical performance worsen, with muscle strength fading more significantly than mobility.

But those who consumed protein more evenly throughout the day appeared to retain greater muscle strength -- though not greater mobility -- than those who consumed most of their protein late in the day.

However, Chevalier stressed the researchers only observed an association between protein distribution and muscle strength, not a direct cause-and-effect relationship.

"In other words, we cannot conclude that older people had greater strength because they were ingesting protein evenly distributed at every meal," she said.

Establishing direct proof would require more research, she said.

Still, the study finding held up regardless of the total amount of protein consumed, she noted.

Prior research has indicated that adults of all ages should consume a minimum of 1.2 grams of protein per kilogram of body weight. (To convert pounds to kilograms, divide your body weight by 2.2.)

For a 155-pound man, that would add up to about three ounces of protein a day, Chevalier said. Spread across breakfast, lunch and dinner, that would mean about one ounce of protein at each meal. A 130-pound woman would require a little less than one ounce per meal.

The U.S. Department of Agriculture's (USDA) Dietary Guidelines call for those over age 50 to consume 5 to 7 ounces of protein foods daily.

In general, one ounce of meat, poultry or fish or one egg or one tablespoon of peanut butter, one-quarter cup of cooked beans or one-half ounce of nuts or seeds qualify as an ounce of protein, according to the USDA.

An outside nutrition expert offered one explanation why the new findings might work.

"Muscle protein is constantly being broken down and built back up. We need protein in our diet daily to make this happen," explained Lona Sandon, a dietetic educator.

That's true at any age, but in late life muscle protein tends to break down faster than it builds up, added Sandon, an assistant professor of clinical nutrition at University of Texas Southwestern Medical Center at Dallas.

Also, research has shown older adults require a higher amount of protein, she said.

"Eating protein throughout the day seems to be a means to stay in a positive protein balance longer than just eating most of your protein for the day in the evening meal," said Sandon.

Sandon said distributing protein intake evenly throughout the day is likely beneficial to everyone, young and old.

Much of the research in this area stems from sports nutrition studies, she added. "This research has also shown a benefit to spreading protein throughout meals over the day for increased muscle mass and strength benefits in active individuals and adults," she added.

However, she cautioned that eating protein alone is not an anti-aging silver bullet.

"You can't just eat a steak and suddenly have bulging biceps," she said, noting the need for some level of physical activity or resistance training as well.

The study was published in the July issue of the American Journal of Clinical Nutrition.

See the article here:
Protein at All 3 Meals May Help Preserve Seniors' Strength - Sioux City Journal

Green Tea Boosts Memory, Combats Obesity – Anti Aging News

EGCG ,a compound in green tea, could alleviate high-fat and high-fructose -induced insulin resistance and cognitive impairment.

Green tea's top catechin and most biologically active component, EGCG, could alleviate cognitive impairment and insulin resistance caused by the consumption of high-fructose and high-fat. This is the determination of researchers from Northwest A&F University's College of Food Science and Engineering. They reached this conclusion after conducting a study centered on mice. The details of the study were recently published in The FASEB Journal.

Insights From Previous Studies

Prior research indicated EGCG had the potential to treat an array of human diseases. However, EGCG's ability to influence insulin resistance and cognitive impairment resulting from the typical Western diet were unclear. The study outlined above has eliminated some of the uncertainty regarding the effects of EGCG.

The Magic of Green Tea

Green tea is consumed more than any other liquid besides water. The tea leaves used for green tea are grown in more than 30 countries. The centuries-old habit of drinking green tea just might be a better alternative to modern medicine in the fight against insulin resistance, obesity and the impairment of memory.

About the Study

The research team separated young mice into three groups according to diet. The first was a control group that consumed a standard diet. The second group was provided with an HFFD diet. The third group was provided with an HFFD diet along with two grams of EGCG for each liter of drinking water. The research team monitored the mice across 16 weeks.

The Results

It was determined the mice provided with HFFD had a higher body weight than the mice in the control group. The HFFD group also had a higher body weight than the mice in the HFFD+EGCG group.

A Morris water maze test was administered. The HFFD mice took longer to reach the platform compared to those in the control group. The HFFD+EGCG mice had a dramatically lower escape distance and escape latency than those in the HFFD group.

The hidden platform was then removed for a probe trial. The mice inthe HFFD group took less time within the target quadrant compared to those in the control group. They also crossed fewer platform crossings than the mice in the control group. The HFFD+EGCG group showed a meaningful increase in the average amount of time spent in the target quadrant. They also had a greater number of platform crossings. Thismeans EGCG might improve memory impairment caused by HFFD.

Original post:
Green Tea Boosts Memory, Combats Obesity - Anti Aging News

Anti-aging medicine group says field isn't 'controversial' – FierceHealthcare

A group dedicated to the advancement of treatment for diseases associated with aging disputes what they describe as a mischaracterization that their field of medicine endorses controversial practices.

The American Academy of Anti-Aging Medicine (A4M) says there is nothing controversial about anti-aging medicine described in an article about Brenda Fitzgerald, M.D., who was recently appointed director of the Centers for Disease Control and Prevention. Fitzgerald is board-certified in anti-aging and regenerative medicine by the organization.

The article noted that some practitioners questioned the choice of Fitzgerald for the high-level government position based on her previous support for anti-aging treatments that they said were unproven and anti-scientific.

It also raised concerns that Fitzgerald partnered with Coca-Cola to run a program against child obesity when she was Georgias public health commissioner. That program focused on physical activity but didnt encourage the need to reduce soda consumption due to its high sugar content.

But Robert Hughes, spokesman for A4M, said in an email to FierceHealthcare that the characterization of anti-aging medicine is false and misleading.

While some may not yet embrace the term anti-aging medicine, there is no controversy over the need for physicians to learn how to stem the rising tide of chronic disease through prevention, lifestyle educationand incorporation of the latest scientific research to help patients live healthier, longer lives, he says. Patients want this. Physicians want this for their patients. A4M provides advanced postgraduate Continuing Medical Education (CME) and training that enables this to occur.

Hughes describes A4M as aU.S. federally registered 501(c)(3) nonprofit organization comprised of more than 26,000 members across the globe, including physicians, scientists and governmental officials, all of whom collectively represent more than 120 nations.

In its 25-year history, he says, A4M has never been the subject of any adverse legal ruling, nor ever been the target of any regulatory procedure or penalty.

We know through experience that, when practiced by trained physicians, the protocols A4M teaches can result in improved patient health. In addition, these techniques help patients avoid chronic conditions that are major drivers of the relentlessly expanding costs of healthcare, he says.

See the rest here:
Anti-aging medicine group says field isn't 'controversial' - FierceHealthcare

Protein at All 3 Meals May Help Preserve Seniors' Strength – The Sentinel

THURSDAY, Aug. 3, 2017 (HealthDay News) -- Eating protein at all three daily meals, instead of just at dinner, might help seniors preserve physical strength as they age, new research suggests.

The Canadian study found that protein-rich meals evenly spread throughout the day staved off muscle decline, but did not increase mobility, in older people.

Study co-author Stephanie Chevalier said, for seniors, "The important point is to create three meal occasions with sufficient protein to stimulate muscle building and greater strength, instead of just one."

Chevalier is an assistant professor of medicine at McGill University in Montreal.

The functional decline associated with aging often leads to falls, mental impairment and loss of independence. Chevalier's team wondered if more evenly distributed protein consumption might be tied to better physical performance and a reduced rate of decline.

To find out, they tracked more than 1,700 relatively healthy Quebec men and women, aged 67 to 84, who were all enrolled in a three-year study.

The participants provided dietary information and underwent yearly hand, arm, and leg strength testing. They were also tested for mobility.

Over the three years, the researchers found that both men and women saw their overall physical performance worsen, with muscle strength fading more significantly than mobility.

But those who consumed protein more evenly throughout the day appeared to retain greater muscle strength -- though not greater mobility -- than those who consumed most of their protein late in the day.

However, Chevalier stressed the researchers only observed an association between protein distribution and muscle strength, not a direct cause-and-effect relationship.

"In other words, we cannot conclude that older people had greater strength because they were ingesting protein evenly distributed at every meal," she said.

Establishing direct proof would require more research, she said.

Still, the study finding held up regardless of the total amount of protein consumed, she noted.

Prior research has indicated that adults of all ages should consume a minimum of 1.2 grams of protein per kilogram of body weight. (To convert pounds to kilograms, divide your body weight by 2.2.)

For a 155-pound man, that would add up to about three ounces of protein a day, Chevalier said. Spread across breakfast, lunch and dinner, that would mean about one ounce of protein at each meal. A 130-pound woman would require a little less than one ounce per meal.

The U.S. Department of Agriculture's (USDA) Dietary Guidelines call for those over age 50 to consume 5 to 7 ounces of protein foods daily.

In general, one ounce of meat, poultry or fish or one egg or one tablespoon of peanut butter, one-quarter cup of cooked beans or one-half ounce of nuts or seeds qualify as an ounce of protein, according to the USDA.

An outside nutrition expert offered one explanation why the new findings might work.

"Muscle protein is constantly being broken down and built back up. We need protein in our diet daily to make this happen," explained Lona Sandon, a dietetic educator.

That's true at any age, but in late life muscle protein tends to break down faster than it builds up, added Sandon, an assistant professor of clinical nutrition at University of Texas Southwestern Medical Center at Dallas.

Also, research has shown older adults require a higher amount of protein, she said.

"Eating protein throughout the day seems to be a means to stay in a positive protein balance longer than just eating most of your protein for the day in the evening meal," said Sandon.

Sandon said distributing protein intake evenly throughout the day is likely beneficial to everyone, young and old.

Much of the research in this area stems from sports nutrition studies, she added. "This research has also shown a benefit to spreading protein throughout meals over the day for increased muscle mass and strength benefits in active individuals and adults," she added.

However, she cautioned that eating protein alone is not an anti-aging silver bullet.

"You can't just eat a steak and suddenly have bulging biceps," she said, noting the need for some level of physical activity or resistance training as well.

The study was published in the July issue of the American Journal of Clinical Nutrition.

See the original post:
Protein at All 3 Meals May Help Preserve Seniors' Strength - The Sentinel

11 Organizations Urge Caution, Not Ban, on CRISPR Germline Genome Editing – Genetic Engineering & Biotechnology News (press release)

Unintended Effects

In a statement to Catholic News Agency earlier this week, Rev.Tadeusz Pacholczyk, Ph.D., director of education for the National Catholic Bioethics Center, expressed moral objection to germline genome editing on embryos: Their value as human beings is profoundly denigrated every time they are created, experimented upon, and then killed. Moreover, if such embryos were to grow up, as will doubtless occur in the future, there are likely to be unintended effects from modifying their genes.

The 11 organizations acknowledged numerous ethical issues arising from human germline genome editing, including:

At a minimum, the potential for harm to individuals and families, ramifications on which we can only speculate, provide a strong argument for prudence and further research, the policy statement asserted. By proceeding with caution, we can ensure better understanding of the potential risks and benefits of gene editing from a scientific perspective and, as such, provide families with a more fulsome exercise of their autonomous decision making through the consent process.

The statement added: We encourage ethical and social consideration in tandem with basic science research in the upcoming years.

Last October, You Lu, M.D., and colleagues at Sichuan Universitys West China Hospital in Chengdu launched the first known clinical trial using CRISPR to treat patientsspecifically, knocking out a gene encoding the programmed death protein 1 (PD-1) in patients with non-small-cell lung cancer.

Groups joining ASHG in issuing the policy statement included the Association of Genetic Nurses and Counsellors, the Canadian Association of Genetic Counsellors, the International Genetic Epidemiology Society, and the National Society of Genetic Counselors.

Additional groups authoring the policy statement were the American Society for Reproductive Medicine, the Asia Pacific Society of Human Genetics, the British Society for Genetic Medicine, the Human Genetics Society of Australasia, the Professional Society of Genetic Counselors in Asia, and the Southern African Society for Human Genetics.

Go here to see the original:
11 Organizations Urge Caution, Not Ban, on CRISPR Germline Genome Editing - Genetic Engineering & Biotechnology News (press release)

LEBRECHT LISTENS | Barenboim Assembles A Dream Team – Musical Toronto

Elgar: The Dream of Gerontius (DG)

Elgar: The Dream of Gerontius (DG)

(out of five)

The first thing you need to know about Daniel Barenboims live performance with the Staatskapelle Berlin is that it is the best-sounding Gerontius on record. No British string section has ever played the work with such sweet serenity. No British winds ever breathed with such deep assurance. Strange as it may seem, the Berlin musicians and chorus singers feel this most English of works in their fingers and bones. There is something akin to love in their playing.

This is not to disparage past recordings, all by English forces, notably the Halles with John Barbirolli and two-thirds of a dream team in Janet Baker and Richard Lewis; or the LPO with Adrian Boult and Nicolai Gedda, Helen Watts and Robert Lloyd. Nor would I want to be without Sakari Oramos recent Birmingham selfie release. All three are passionate accounts. This one just sounds lovelier, less effortful. The critical faculty of disbelief is suspended for the duration.

Daniel Barenboim shares with the composer a breezy agnosticism and a love for English moderation. His approach to the oratorio is broadsided, utterly secure, without shocks or fancy gestures. The intended soloists were Jonas Kaufmann, Sarah Connolly and Thomas Hampson. The first two called in sick, to be replaced by Catherine Wyn-Rogers and Andrew Staples. Their voices are, perhaps, a shade less full but the cohesion of soloists, orchestra and chorus is admirable. Never a huge devotee of post-Handel English oratorios, I dont think Ive enjoyed a Gerontius this much before.

Elgar: The Dream of Gerontius (DG) is available atAmazon.co.uk.

Norman Lebrecht is one of the most widely-read commentators on music, culture and cultural politics. He is a regular presenter on BBC Radio 3 and a contributor to the Wall Street Journal, Bloomberg, Standpoint, Sinfini and other publications. His blog, Slipped Disc, is among the most widely read cultural sites online, breaking exclusive stories and campaigning against human abuse and acts of injustice in the cultural industries.

Read the rest here:
LEBRECHT LISTENS | Barenboim Assembles A Dream Team - Musical Toronto

Keeping pace with momentum investors, ignoring the VIX and why it may be time to buy Canadian – The Globe and Mail

Long ago when I was a mutual fund analyst, I would tell the brokers that if they let me pick the beginning and end dates for performance history, I could prove both that it was a great buying opportunity and it was among the worst funds in its category.

Take Mackenzie Financials Cundill Value Fund (a fund I liked a lot in my previous life) as an example. To prove it was a great buy, it would be easy to emphasize the 2016 returns where the funds 10.5 per cent appreciation outpaced the average global equity fund by more than 700 basis points. To argue the fund was mediocre, Id point to the three year average annual return that was worse than 95 per cent of the competition.

So is it a good or bad fund? Neither, at least based on this cursory look at performance.

Each fund, and by extension each investing style, is best suited to specific market conditions.

The momentum investing strategy, with its agnosticism on valuations and emphasis on stock price and earnings strength, has been the top performer in the past five years. Momentum-based managers have been comfortable holding the extremely expensive FANG stocks that were leading global equity markets higher, as long as their prices and earnings continued to climb.

Im not suggesting history is about to repeat itself but momentum investors were also riding high in the late 1990s, with a similar dependence on the technology sector, before getting obliterated in the 2000 to 2002 period.

For mutual funds and individual investor portfolios, all performance data must be taken in context. An investor with strong trailing portfolio returns over the past five years has every right to be proud of themselves, but they also have to make sure that their holdings are also positioned to benefit from the next five years.

Are the same growth drivers that drove returns in the past in many cases technology stocks and dividend paying companies benefitting from declining interest rates sustainable?

-- Scott Barlow is The Globe's in-house market strategist

This is the twice a week Globe Investor newsletter. If someone has forwarded this e-mail newsletter to you, you can sign up for Globe Investor and all Globe newsletters here.

NEW: Get the new Evening Update newsletter, a summary of the day's headlines put together by Globe editors, or the new Real Estate newsletter, covering the housing market, mortgages, deal closing, design and more. Sign up here

Stocks to ponder

Air Canada. The airline demonstrates just how fickle the business can be. The carriers gains this week take its stock back only slightly beyond the $21 a share it went public at in 2006. For investors, the past 11 years have been one long round trip. Ian McGugan examines the industry.

BSM Technologies Inc. The Toronto-based company, whose equipment and software help owners of truck, rail and other fleets track their vehicles, has grown through acquisition and could be a takeover target, according to David Barr, president of PenderFund Capital Management Ltd. in. Vancouver. Shirley Won looks at six budding stocks that trade for less than $5 a share.

AcuityAds Holdings Inc. The Toronto-based technology firm has rallied 89 per cent year-to-date. There are six buy recommendation on the stock with a 46-per-cent price return anticipated over the next year. Jennifer Dowty analyzes at the stock.

Ross Stores Inc. This discount fashion retailer is a seemingly contrarian pick given the pressure on retailers from e-commerce giants such as Amazon.com. But it passes all the criteria Berkshire Hathaway would use. John Reese examines three stocks from a Warren Buffett-inspired portfolio.

Theratechnologies Inc. Shares of the specialty pharmaceutical company have shot up nearly 200 per cent over the past year on the promise of a newer product and some analysts say the run may not be over yet, according to Brenda Bouw.

Cineplex Inc. The industry leader that took a rare tumble on Wednesday, falling over 8 per cent. For patient long-term investors, this pullback may represent a buying opportunity with a potential reacceleration in the share price in late-2017 or early-2018. Jennifer Dowty breaks down the stock.

The Rundown

Investors, heres a case for buying CanadaCanadian investors have been criticized since forever for having too much of a home bias. In that context, the push into international ETFs is laudable. Now, investors seem to have a home aversion to some extent, according to Rob Carrick.

Why investors shouldnt be reading too much into the fear indexPessimists see the decline of the VIX and disappearance of volatility as evidence of investor complacency a dangerous precursor to many of historys most severe corrections. But while an underappreciation of the markets risks is a legitimate concern, many investors are putting too much stock in the VIX index, writes Tim Shufelt.

Its the world, not Donald Trump, thats making the Dow great againWhile the U.S. President may want to make America great again, his countrys major stock indexes are globalized to an extent that surprises many investors. The companies in the S&P 500, a broadly based index of large U.S. businesses, derived 44.3 per cent of their sales from outside the United States in 2016, according to S&P Dow Jones Indices. Ian McGugan explains.

Canada should fight for shareholder rightsAt some point, someone tries to take things just too far, and all hell breaks loose. This is what happened when Snap Inc., owner of the Snapchat messaging app, went public earlier this year in the United States with shares that gave investors no vote at all on virtually all corporate matters, writes David Milstead.

How to make the right choices when investing in REITsReal estate investment trusts should be an integral part of every income investors portfolio. They offer steady income, relative safety, and tax advantages if held outside a registered plan. The question is, how should you hold them? Gordon Pape explores the possibilities.

Others

Rob Carrick: The financial disadvantages of living alone

Charity fund managers navigate difficult second quarter

Fridays Insider Report: Companies insiders are buying and selling

Thursdays Insider Report: Companies insiders are buying and selling

Wednesdays Insider Report: Companies insiders are buying and selling

Number Crunchers

Eight U.S. restaurant stocks that are looking oversold

Eleven Canadian stocks with solid fundamentals that analysts ignore

Fifteen large-cap stocks built to weather the storm

Ask Globe Investor

Do you have a question for Globe Investor? Send it our way via this form. Questions and answers will be edited for length.

Whats up in the days ahead

Click here to see the Globe Investor earnings and economic news calendar.

More Globe Investor coverage

For more Globe Investor stories, follow us on Twitter @globeinvestor

Click here share your view of our newsletter and give us your suggestions.

Want to subscribe? Click here to sign up or visit The Globe's newsletter page and scroll down to the Globe Investor Newsletter.

Compiled by David Leeder

Follow us on Twitter: @GlobeInvestor

Read more:
Keeping pace with momentum investors, ignoring the VIX and why it may be time to buy Canadian - The Globe and Mail

David Hume and the Shroud of Turin – Patheos (blog)

So The alternative to the miraculous answer is always to be preferred because it will always be more probable.

In other words, Miracles are impossible therefore miracles dont happen.

As more and more scientific research is completed on the Shroud of Turin, however, Humes argument becomes more and more strained.

The toss up is this: The Shroud of Turin is either the burial cloth of Jesus Christ on which is recorded evidence of the resurrection OR it is a forgery OR it is just a mysterious artifact for which we do not yet have a natural explanation.

The most stunning evidence from the shroud is the mysterious image itself. The image was not painted. It was not burnt on with conventional heat application processes. According to the latest research by Dr Paolo Lazzaro, the image was seared onto the linen by a super intense blast of ultra violet light. Not only was this impossible in the Middle Ages, but it is impossible today. We dont have the technology to reproduce this kind of image.

Therefore we need to ask, which is more difficult to believethat the Shroud is the burial cloth of Jesus or that some medieval forger was able to blast ultraviolet light on the shroud to produce the image in a manner still undeterminedusing a technology that is still way beyond that available today?

It is actually easier to believe that the Shroud is authentic.

The only other option (and one which an increasing number of Shroud skeptics take) is to shrug and say, Well, it is a mysterious artifact that we cannot explain.

But when you add that the image not only shows a crucified man, but a crucified man with the particular distinguishing marks of Jesus Christ crucifixion (the crown of thorns, the unbroken legs, the spear wound in the side, the flogging) it becomes increasingly difficult to maintain such disinterested agnosticism.

I suppose the authenticity of the Shroud will never be proven in a completely watertight way, but with the accumulation of evidence it is increasingly difficult to deny.

If, according to Hume, we must choose the most probable answer we would choose the proposal that it is the burial cloth of Christ and the image is supernatural evidence of his resurrection.

In other words, in this one case, the miraculous answer is the most probable.

Read the original here:
David Hume and the Shroud of Turin - Patheos (blog)

Genesis Biotechnology Group Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch – Markets Insider

HAMILTON, N.J., Aug. 3, 2017 /PRNewswire/ --Genesis Biotechnology Group (GBG), a consortium of vertically-integrated entities that are concentrated in Drug Discovery and advanced, state-of-the-art molecular diagnostic services, such as next-generation sequencing and bioinformatics to aid in the detection of chronic complex diseases, announced today the asset acquisition of 4path, LTD (4path), an Anatomic and Clinical Pathology Laboratory facility located in Burr Ridge, IL. Financial terms were not disclosed.

Medical Diagnostic Laboratories, L.L.C. (MDL), a molecular diagnostic testing service company and a member of GBG, has a proven track record of service excellence and cost-efficiency through the effective use of advanced automation and robotic technology. With this collaboration, patients and providers in the Great Lakes region will have increased access to advanced molecular diagnostic assays and an expanded menu of cytopathology and histology services in multiple specialties such as Gynecology, Gastroenterology, Urology, Breast, Podiatry, and Dermatology. This collaboration also brings a dedicated sales force to expand 4path's relationship to clients in a larger geographic area, establish a rapid-response clinical laboratory to reduce turnaround time in the mid-west region, and fund future strategic growth initiatives.

According to Dr. Eli Mordechai, GBG's CEO, "This collaboration is an excellent fit with our mission to improve patient care and advance the quality of treatment options through the development and delivery of world class diagnostics. It brings together highly complementary services that enable clients to have access to a comprehensive portfolio of clinical diagnostic services in multiple therapeutic areas." This spirit of collaboration was supported by Stephen G. Ruby, MD, MBA of 4path, Ltd, who stated, "As Medical Director of 4path, I am pleased to have this relationship with the GBG family of healthcare businesses.We look forward to expanding the scope of services available to our physician base and providing them with the specialized laboratory support for their patients."

About GBGGBG is a consortium of vertically-integrated corporate diagnostic and research entities, which facilitates the overall market implementation and delivery of biomedical science products and services related to diagnostics and drug discovery. The Diagnostic segment of GBG utilizes high complexity, state-of-the-art, automated molecular analysis to offer clinicians from many different specialties valuable diagnostic information to assist in the detection, diagnosis, evaluation, and treatment of complex disease. Through the integration of research activities and the collaboration of diverse groups of scientists with expertise in molecular biology, genetics, high throughput screening (HTS), pharmacology, molecular modeling, and medicinal chemistry, GBG will be better positioned to provide complex diagnostic platforms in infectious disease, genetic-based testing, cancer diagnostics, and drug resistance profiling.

About 4path, Ltd4path, Ltd is a College of American Pathologists (CAP) Accredited Laboratory in the Chicago metropolitan area, which has provided Anatomic Pathology services to clients in the Great Lakes Region for over 10 years. Their team of board-certified pathologists provides highly personalized diagnostic services with expertise in Podiatry, Gastroenterology, Urology, Dermatology, Breast, Gynecology, Orthopedics and other specialties.

To find out more, please visit http://www.genesisbiotechgroup.com or http://www.4path.com.

Contact:

Ben Bandaru, Director of Mergers & Acquisitionsrel="nofollow">170782@email4pr.comDirect: 609.245.7507www.genesisbiotechgroup.com

View original content with multimedia:http://www.prnewswire.com/news-releases/genesis-biotechnology-group-acquires-assets-of-4path-ltd-to-expand-their-diagnostic-branch-300498985.html

SOURCE Genesis Biotechnology Group

Go here to see the original:
Genesis Biotechnology Group Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch - Markets Insider

Scientists, Theologians Ponder If Latest Biological Findings Are More Compatible With Religion – Sojourners

When Charles Darwin published his landmark theory of evolution by natural selection in the 19th century, religious leaders were confronted with a powerful challenge to some of their oldest beliefs about the origins of life.

Then evolutionary theory was expanded with the insights of genetics, which gave further support for a scientific and secular view of how humans evolved.

Faith and tradition were forced further onto the defensive.

Now, exciting progress in biology in recent decades may be building up a third new phase in the scientific explanation of life, according to thinkers gathered at a University of Oxford conferencefrom July 19-22.

Although this 21st-century wave has no single discovery to mark its arrival, new insights into developing technologies such as genetic engineering and human enhancement may end up giving another important boost to the belief that science has (or eventually will have) the answers to lifes mysteries.

Some scientists, theologians, and philosophers see in this ever deeper knowledge of how genes work a possible alternative to the more reductive approach to evolution one that brings in a broader view that also considers the influence of the environment.

Unlike the earlier views, which seemed to lead toward either agnosticism or atheism, the theologians see this new biology or holistic biology as more compatible with religious belief.

Weve added definition to the picture of evolution that has deepened and enriched our understanding of biological processes, Donovan Schaefer, an Oxford lecturer in science and religion who co-organized the conference, told the opening session of the July 19-22 meeting.

But he added: It would be naive to imagine that the grander questions about biology, religion, the humanities, and evolutionary theory generally have been put to death.

The achievements on their list include new fields like epigenetics, the science of how genes are turned on or off to influence our bodies, and advances in cognitive and social sciences that yield ever more detailed empirical research into how we behave.

Waiting in the wings are new technologies such as genome editing, which can modify human genes to repair, enhance, or customize human beings. Scientists in China are believed to have already genetically modified human embryos, and the first known attemptto do so in the United States was reported on July 26.

Schaefer compared todays deeper understanding of biology to the higher resolution that photographers enjoy, now that photography has advanced from film to digital images.

Genes once thought to be fairly mechanical in influencing human development leading to the my genes made me do it kind of thinking have been found to be part of complex systems that can act in response to a persons environment.

Since scientists succeeded in sequencing the genome in the late 1990s, they have found that epigenetic markers that regulate patterns of gene expression can reflect outside influences on a body.

Even simpler living objects such as plants contain a complex internal genetic system that governs their growth according to information they receive from outside.

To theologians who see a new biology emerging, this knowledge points to a more holistic system than scientists have traditionally seen, one more open to some divine inspiration for life.

In this view, the fact that epigenetic markers can bring outside pressures to bear on the genome deep inside a human means genetics is not a closed system, but part of the wider sweep of nature in which they, as religious thinkers, also see Gods hand.

Nature is so complex and rich, and that prompts questions about why on earth is this the case? If youre an atheist, how do you explain a universe that seems to have the capacity to produce these things in the first place? asked Alister McGrath, an Oxford theologian who is director of the Ian Ramsey Centre for Science and Religion that hosted the conference.

This in turn opened a space for theologians to augment the discussion about the new biology, he said.

Massimo Pigliucci, a philosopher at New Yorks City College with doctorates in genetics and evolutionary biology, also said scientism the idea that science can answer all lifes important questions was too limited.

Science informs and grounds certain philosophical positions; it doesnt determine them, he said. But the data cant settle ethical questions.

Pigliucci agrees with the trend to use the evolutionary paradigm to analyze fields outside of biology, including topics such as ethics and morality.

The life sciences tell us that the building blocks of what we call morality are actually found presumably they were selected for in nonhuman social primates, he said. Science gives you an account of what otherwise looks like magic: Why do we have a moral sense to begin with? How did we develop it?

Not all present agreed that science could explain religion.

Some suspect that biology has triggered some kind of devotion and there are too many people who practice this cult, said Lluis Oviedo, a theologian at the Pontifical University Antonianum in Rome.

His own research has found at least 75 books and academic articles trying to explain religion through evolution, and he knew of about 20 more on the way, he said.

Although he thinks, the time of explaining through radical reduction is over, he admitted few biologists seemed ready to accept the more holistic new biology.

Even some scientists at the conference, while ready to engage with the philosophers and theologians, showed less interest in discussions about whether a new biology was emerging.

Im pragmatic, explained Ottoline Leyser of the University of Cambridge, whose lecture on plant genetics was one of the conferences highlights.

Theologians in the decades long science and religion debate, which argues the two disciplines complement each other, have also become more pragmatic as their dialogue proceeds.

Oxfords McGrath said the theologians had become more modest in the claims they made about what religion could contribute to this debate. Unlike some more doctrinaire scientists, he said, they did not think they had all the answers.

They dont say These observations in nature prove or disprove God, he said. Our religious way of thinking gives you a framework which allows you to look at the scientific approach to the world and understand why it makes sense, but at the same time also to understand its limits.

Those things need to be in the picture if were going to lead meaningful lives.

Via Religion News Service.

See original here:
Scientists, Theologians Ponder If Latest Biological Findings Are More Compatible With Religion - Sojourners

Do these 4 natural anti-aging alternatives work? – Fox News

In anti-aging skin care, there are many alternative treatments you'll come across, from skin-needling to Ayurvedic medicine to a diet detox, but all of them aren't created equal.

We asked skin care professionals which ones are worth your time and moneyand which ones you can skip. (We've also got loads of good natural skin care tips and tricks, from coconut oil to rosehip oil based moisturizers, to masks containing that anti-bacterial beauty balm, honey.) Below, we break down everything you need to know about four popular treatments.

RELATED: 6 MOST IMPORTANT BEAUTY PRODUCTS TO BUY ORGANIC

AYURVEDIC MEDICINE

This system of traditional Indian healing relies on techniques such as diet changes, breathing exercises and botanical medicine to treat patients based on their dosha, or "mind-body type."

Does it work?

"The doshas seem to line up with skin types we're familiar with," says Jasmina Aganovic, an MIT-trained chemical and biological engineer and founder of the Stages of Beauty skin-care line. "The Vata dosha typically coincides with dry skin," she says, "Pitta coincides with sensitive; and Kapha, with oily or combination skin."

Even so, there's no scientific evidence that treating your skin based on your dosha is beneficial, says Susan Stuart, MD, a dermatologist in San Diego. However, there is proof that many of the powerhouse plant-based ingredients used in Ayurvedic medicine can help you look younger.

For example, "research shows that turmeric and ginger, both used frequently in Ayurvedic medicine, can reduce wrinkles," says Shyam Gupta, PhD, a chemist and founder of Bioderm Research, a cosmetic research company in Scottsdale, AZ. And several studies show that grapeseed extract, another Ayurvedic ingredient, protects against photodamage.

RELATED: I TRIED DRINKING FRESH TURMERIC JUICE EVERY DAY FOR A MONTHHERES WHAT HAPPENED

Bottom Line

Try healing Ayurvedic recipes, and products with Ayurvedic ingredients like turmeric and ginger, but don't overhaul your beauty regimen based on your dosha just yet.

ALKALINE DIET

A few studies have shown acidity can be damaging to the body, so it's thought by some that eating mostly alkaline-forming (or, acid-lowering) foods like fruits and vegetables may slow skin aging.

Does it work?

There's no research proving this theory. Our bodies do a good job of regulating acidity regardless of diet. But there is anecdotal support: "My clients who eat 80% alkaline-forming foods notice fewer lines and more hydrated skin in weeks," says author and nutritionist Kimberly Snyder.

Bottom Line

The diet won't erase wrinkles, but eating more fruits and veggies improves overall health (including preventing weight gain)and that can only be good for skin.

SKIN NEEDLING

In this procedure, you roll a small needle-covered device over your face to create tiny, temporary pricks in your skin, which may trigger a healing response (similar to what occurs after a cut), leading to a smoother complexion.

Does it work?

San Francisco dermatologist Kathy Fields, MD, who helped develop a home skin needling package with a peptide-and retinol-based serum for Rodan + Fields, says her company's analysis shows using it can induce skin's collagen-building process and improve penetration of anti-aging ingredients applied afterward. But there aren't peer-reviewed studies of at-home devices, and Dr. Stuart believes needling is safer and more effective done in a dermatologist's office with a pro version of the tool.

Bottom Line

Used before a retinol-based product, an at-home skin-needling tool can smooth skin, but it's likely the retinol doing most of the work. Check with your dermatologist first.

RELATED: 11 OLD FASHIONED BEAUTY TREATMENTS GRANDMA USED THAT YOU SHOULD TOO

DIET CLEANSE

Some experts think that temporarily restricting your diet (whether with a cleanse, a juice fast or a similar detox plan) can clarify your complexion and make your skin glow.

Does it work?

"Most people's skin improves when they do a cleanse because they're removing foods that have a pro-inflammatory effectand inflammation is the root of many skin issues, including rosacea, acne and premature aging," says Frank Lipman, MD, an integrative physician and founder of Eleven Eleven Wellness in New York City. Although it's best to have an integrative medicine expert guide you in the cleansing process, it's possible to see benefits on your own.

RELATED: 7 DIY FACE MASKS AND SCRUBS THAT ACTUALLY WORK

Dr. Lipman says avoiding caffeine, sugar, dairy, gluten and meat for a few weeks can offer a short-term boost to your complexion. Research supports this theory to some extent (gluten intolerances have been linked to skin issues for some people, and several studies have shown a correlation between dairy consumption and acne). However, Mary Lupo, MD, a dermatologist, says there are no studies showing that a temporary cleanseno matter what types of food are restrictedcan reduce cellular inflammation or provide long-term skin benefits.

Bottom Line

A cleanse won't turn back the clock, but eating less sugar and fewer starchy carbohydrates could be beneficial in the long run, and help you determine what's potentially throwing off your body chemistry. "These foods can spike blood glucose levels, and that accelerates aging of all organs, including the skin," says Dr. Lupo.

This article originally appeared on Rodale Organic Life

The rest is here:
Do these 4 natural anti-aging alternatives work? - Fox News

When P.M. Bhargava’s Biochemistry Lesson on Beef Threw … – The Wire

After Bhargava organised a controversial meeting at a research lab in Hyderabad in 1967, he was summoned by a committee set up by the Centre to be quizzed abouthis meat-eating preferences. Golwalkar was part of the committee.

Credit: richichoraria/pixabay

The following is an excerpt from a biography of Pushpa Mittra Bhargava, currently in preparation by Chandana Chakrabarti, and from a biography of Verghese Kurien. Bhargava passed away on August 1, 2017. He was 89years old. The excerpts have been lightly edited for style.

The year 1966 witnessed a mass agitation against cow slaughter organised by the [Rashtriya Swayamsevak Sangh (RSS)]. The demand was for a complete ban on cow slaughter in the country. It culminated in a huge demonstration lead by sadhus who tried to storm the Parliament house in Delhi. While the Shankaracharya of Puri went on a fast for the cause, the frenzied mob went on a rampage. A 48-hour curfew had to be imposed to control the situation.

It was against this background that the Society for the Promotion of Scientific Temper held a public discussion at the Regional Research Laboratory in Hyderabad in 1967, on the relevance of a ban on cow slaughter, with Dr Pushpa Bhargava (PMB) chairing it. At this meeting, one of the speakers, Dr P. Ramchander, a well-known physician, said, If we dont eat the cows, the cows will eat us. This caught the headlines of newspapers the following day. The statement offended those who were asking for the ban and PMB promptly started receiving verbal threats. Questions were asked as to how could PMB organise such a meeting in a government laboratory.

Subsequently, the Government of India set up a high power committee headed by Justice Sarkar, a former Chief Justice of India, to look into the issue. Guru Golwalkar, the head of RSS, Shankaracharya of Puri, Verghese Kurien (the Milk Man of India), and H.A.B. Parpia, the director of the Central Food Technological Research Institute, were members of the committee. PMB was summoned to Delhi to give evidence before the committee.

When PMB arrived at Krishi Bhavan to appear before the committee, a man sitting in the waiting room immediately started quizzing him about cow slaughter. His questions were unending: was PMB a Brahmin since Bhargavas are supposed to be Brahmins?; did PMB eat meat?; if he does eat meat he surely does not eat cows meat?; how does the body make meat?; and so on. PMB ended up giving the man a crash course in elementary biochemistry, saying that we eat food which has proteins. Those proteins are broken down in our [gastrointestinal]tract into amino acids, which are absorbed into the blood stream, and they go to various organs, where they get reconverted to proteins. But how is milk made, the man asked. Milk is made exactly in the same way as meat, PMB replied. Then why dont you drink milk instead of eating meat, the man asked. Why dont you eat meat like you drink milk, because both are made the same way, PMB replied. To PMBs surprise, this little encounter proved to be a curtain-raiser to what unfolded when he appeared before the committee.

Inside the meeting room, Guru Golwalkar asked PMB exactly the same questions. And when PMB replied to Golwalkars question, as to why he did not drink milk instead of eating meat, with another question that is, why by the same logic did Golwalkar not eat meat instead of drinking milk Golwalkarwent into a fit of rage. It took quite a while for the chairman and Sankaracharya to calm him down. Shankaracharya pleaded with Golwalkarthat he was spoiling their case. After PMB came out, he got a slip from Justice Sarkar asking to meet him before he left. Justice Sarkar cheerfully told PMB that he was fantastic and added that the only person who did better than PMB was a professor of Sanskrit who appeared before the committee and quoted from ancient Indian literature on the advantages of eating beef.

As it turns out several years later, while collecting material for a joint paper on biology in India from ancient times to 1900, PMB and I stumbled across the following statement made in the Charaka Samhita:

The flesh of the cow is beneficial for those suffering from the loss of flesh due to disorders caused by an excess of vayu, rhinitis, irregular fever, dry cough, fatigue, and also in cases of excessive appetite resulting from hard manual work.

Three decades later, PMB went to see Kurien in Anand, Gujarat, along with a friend. When PMB reminded Kurien about the incident, Kurien told him that over the years when he and Golwalkar became close friends, the latter admitted to him that the cow protection agitation was only a political agitation which he started to actually embarrass the government. Kurien would later describe this episode in his biography, which was titled I Too Had a Dream.

One day after one of our meetings when he had argued passionately for banning cow slaughter, he came to me and asked, Kurien, shall I tell you why Im making an issue of this cow slaughter business ?

I said to him, Yes, please explain to me because otherwise you are a very intelligent man. Why are you doing this ?

I started a petition to ban cow slaughter actually to embarrass the government, he began explaining to me in private. I decided to collect a million signatures, for this work I traveled across the country to see how the campaign was progressing. My travels once took me to a village in Uttar Pradesh. There, I saw in one house a woman who, having fed and sent off her husband to work and her two children to school, took this petition and went from house to house to collect signatures in that blazing summer sun. I wondered to myself why this woman should take such pains. She was not crazy to be doing this. This is when I realised that the woman was actually doing it for her cow, which was her bread and butter, and I realised how much potential the cow has.

Look at what our country has become. What is good is foreign;what is bad is Indian. Who is a good Indian? Its the fellow who wears a suit and a tie and puts on a hat. Who is a bad Indian? The fellow who wears a dhoti. If this nation does not take pride in what it is and merely imitates other nations, how can it amount to anything ? Then I saw that the cow has potential to unify the country she symbolises the culture of Bharat. So I tell you what, Kurien, you agree with me to ban cow slaughter on this committee and I promise you, five years from that date, I will have united the country. What Im trying to tell you is that Im not a fool, Im not a fanatic. Im just cold-blooded about this. I want to use the cow to bring out our Indianness. So please cooperate with me on this.

Chandana Chakrabartiis a biologist, consultant and joint secretary of the P.M. Bhargava Foundation, Hyderabad.

What to read next:

Categories: Featured, History, Politics, Science

Tagged as: beef, biochemistry, Cow slaughter, Guru Golwalkar, Justice Sarkar, nationalism, Pushpa Mittra Bharghava, Rashtriya Swayamsevak Sangh, Verghese Kurien

Continued here:
When P.M. Bhargava's Biochemistry Lesson on Beef Threw ... - The Wire

Cancer survivor becomes a cancer fighter at a Philly start-up – Philly.com

What Debra Travers really wanted to be was a marine biologist, until I found out Jacques Cousteau wasnt hiring.

How she wound up as chief executive of PolyAurum LLC, a Philadelphia start-up developing biodegradable gold nanoparticles for treating cancerous tumors, involved a professional journey of more than 30 years in pharmaceutical and diagnostics industries, and a personal battle with the disease shes now in business to defeat.

After determining that studying sea creatures was not a viable career choice, Travers a military kid from all over switched her major at Cedar Crest College in Allentown to medical technology. She graduated in 1979, then worked for three years in a hospital laboratory until she concluded she didnt like shift work and could do more.

What followed was an impressive career progression: Travers started as a chemistry technician at DuPont Biomedical Products Division, advancing to executive positions in marketing and product development at Centocor, GlaxoSmithKline, Endo Pharmaceuticals, and IMS Health.

Much of that work involved bringing new products through the long development and regulation-heavy process from concept to launch, with experience in therapeutic areas including oncology, urology, pain medicine, cardiology, and rheumatology. In an industry of specialty silos, Travers developed a uniquely blended expertise in marketing and R&D.

It was on March 23, 2006, that her health-care vocation turned personal: Travers, then a 50-year-old mother of two, was diagnosed with breast cancer.

An oncologist recommended a double mastectomy, removal of both ovaries, and chemotherapy. The tearful pleadings of her daughter, Kelly, then 18 I need you here when I graduate college, when I get married, when I have kids persuaded Travers to follow that recommendation.

She returned to work at Endo for seven more years, as a director in project management, before being laid off in June 2013, one month before her daughters wedding. The break gave Travers time to concentrate on the big event and to start to think what Id like to do when I grow up.

That process would lead her in late 2015 to PolyAurum, a start-up spun out of the University of Pennsylvania.

I became a CEO and a grandmother in the same year, said Travers, now 61, chuckling during a recent interview at the Pennovation Center incubator in West Philadelphia. From there, her home in Delaware, and the sites of pitch opportunities with investors, she is working to raise $1.3 million in seed funding by early in the fourth quarter, to help get PolyAurum closer to clinical trials on humans.

So far, research and testing funded through $4 million in grants to the university has been limited to mice with tumors. It has shown that gold nanocrystals greatly enhance the effectiveness of radiation on tumors without increasing harm to healthy surrounding tissue, said Jay Dorsey, an associate professor and radiation oncologist at Penn and one of four university faculty who developed the technology.

The effectiveness of metals in improving a tumors ability to absorb radiation has long been known, Dorsey said. But one of the stumbling blocks to incorporating gold nanoparticles in such therapeutics is that the metal is not eliminated from the body well, posing serious problems to vital organs such as the liver and spleen.

Penns David Cormode, a professor of radiology, and Andrew Tsourkas, a professor of bioengineering, have worked to make gold more biocompatible, resulting in PolyAurums current technology, Dorsey said. The gold nanocrystals are contained in a biodegradable polymer that allows enough metal to collect in a tumor. The polymer then breaks down, releasing the gold for excretion from the body so that it does not build up in key organs.

The companys name is a combination of those two essential ingredients: Poly, derived from polymer, and Aurum, the Latin word for gold.

Explaining all that, and the potential that PolyAurums founders see for extending and saving lives, is the message Travers now is in charge of disseminating the part of the critical path to commercialization that is not the strength of most researchers toiling in laboratories.

She knows what the founders dont know it just makes a perfect match, said Michael Dishowitz, portfolio manager at PCI Ventures, an arm of Penn that helps university start-ups find investors, recruit management, and get to market.

Since its formation about eight years ago, PCI has helped more than 150 companies secure more than $100 million in funding, said Dishowitz, who has a doctoratein bioengineering from Penn and spent several years studying the impact of cell-signaling pathways on orthopedic injury.

While calling PolyAurums technology cool and very transformative for treatment, Dishowitz also delivered a dose of reality about the rigors ahead, as health-care start-ups must navigate a course with no guarantees their products will lead to actual clinical implementation.

PolyAurum is one of 13 companies that entered Philadelphia Media Networks second annual Stellar StartUps competition in the health-care/life sciences category. A total of nine categories drew 88 applicants. The winners will be announced Sept. 12 at an event at the Franklin Institutes Fels Planetarium. (Details at http://www.philly.com/stellarstartups.)

A lot has to go right, all the planets and stars have to align for this to hit the market, Dishowitz said of PolyAurums commercial prospects.

Which is why the team behind any start-up is so essential to investors, he said, calling Travers interest in joining a company that has yet been unable to pay her (she has equity in PolyAurum) incredibly lucky.

Margo Reed

At the Nanomedicine and Molecular Imaging Lab at Penn Medicine are (front row, from left) Jay Dorsey, a radiation oncologist and a founder of PolyAurum; Debra Travers, CEO; and Andrew Tsourkas, another founder of PolyAurum; and (back row, from left) Michael Dishowitz, portfolio manager, PCI Ventures at Penn; and David Cormode, lab director and PolyAurum founder. (MARGO REED / Staff Photographer)

The only thing Travers corporate-heavy background lacked, he said, was raising money for a start-up. It doesnt worry him, Dishowitz said, citing Travers perseverance, no-quit attitude.

When youre out there raising money, youre going to hear no about 100, 150 times before you hear yes, Dishowitz said.

When it comes to pitching for PolyAurum, Travers has extra incentive.

I am working on a cancer therapeutic, which is very important to the 11-year cancer survivor in me, she said.

As for handling nos, shes had plenty of professional experience with that.

After spending 30-plus years in the drug and diagnostic industries, where it is hard to find women CEOs or board members, Travers said, Ive learned to ignore the negative voices.

When: 5:30-8:30 p.m. Tuesday, Sept. 12.

Where: Fels Planetarium, Franklin Institute, 222 N. 20th St., Philadelphia 19103

For more information: http://www.philly.com/stellarstartups

Published: July 28, 2017 3:01 AM EDT

We recently asked you to support our journalism. The response, in a word, is heartening. You have encouraged us in our mission to provide quality news and watchdog journalism. Some of you have even followed through with subscriptions, which is especially gratifying. Our role as an independent, fact-based news organization has never been clearer. And our promise to you is that we will always strive to provide indispensable journalism to our community. Subscriptions are available for home delivery of the print edition and for a digital replica viewable on your mobile device or computer. Subscriptions start as low as 25 per day.We're thankful for your support in every way.

Read the rest here:
Cancer survivor becomes a cancer fighter at a Philly start-up - Philly.com

A Delegation led by Director Li Weimin of West China Hospital, Sichuan University Visited the UK – Markets Insider

CHENGDU, China, Aug. 2, 2017/PRNewswire/ -- On July 9-14 this year, a delegation led by director Li Weimin of West China Hospital, Sichuan University visited University of Liverpool, Cambridge University Hospitals, and Imperial College London in the UK. The delegation consisted of representatives from multiple departments and divisions of West China Hospital, Sichuan University, including Integrated TCM & Western Medicine Department, Cardiac Surgery Department, Anesthesiology Department, Health Care Division, Biological Specimen Bank, Information Center, and International Exchange and Cooperation Office.

While at University of Liverpool, the delegation visited its core medical research departments including Clinical Research Center, Research Accelerator,North West Cancer Research Centre, Biobank, Institute of Integrative Biology, and Institute of Translational Medicine, and held discussions with the host about potential cooperation in the field of biomedical research in the future.

On July 10, a bilateral cooperation forum was organized, and leaders and experts from University of Liverpool and Royal Liverpool Universityparticipated. In this forum, director Li Weimin reviewed the cooperation history between University of Liverpool and West China Hospital, stating that University of Liverpool had cultivated nearly ten talents for West China Hospital and that reinforced cooperation would greatly benefit both parties due to their traditional focus on scientific research. Executive vice director Wan Xuehong gave an overview of West China Hospital, and recommended further cooperation plans with regard to doctor and post-doctor cultivation, expert exchange, and joint establishment of West China Liverpool Biomedicine Research Center and Liverpool West China Center. After the forum, director Li Weimin signed a Liverpool - West China cooperation memorandum with Bob Burgoyne, executive pro-vice-chancellor of University of Liverpool and dean of Faculty of Health and Life Sciences.

While at Cambridge University, the delegation met the managers of remote medical platform UKeMED, and communicated with representatives from institutes such as Cambridge University Hospitals and University of Bedfordshire. The delegation also made a video presentation about world leading medical technologies of West China Hospital. After the meeting, director Li Weimin and Takis Kotis, CEO of UKeMED Platform, signed a cooperation memorandum concerning remote medicine and education as well as a letter of intent for cooperation under The Belt and Road initiative.

On the afternoon of July 12, the delegation met Roland Sinker, CEO of Cambridge University Hospitals. Later, the delegation paid a visit to Biomedical Research Centre (BRC) Of Cambridge University, during which discussions were held with experts of the centre about challenges confronted by West China Hospital in biomedical research.

During their stay in London, the delegation visited Health care UK (HCUK). Ms. Deborah Kobewka, managing director of HCUK, introduced NHS medical system of UK and its operation conditions to the team members. She described HCUK as a government interface between UK and foreign medical partners, welcoming cooperation between West China Hospital and famous UK organizations like Cambridge UKeMED. The delegation also visited four private high-end UK medical centers at Harley Street. The team led by Director Li Weimin and executive vice director Wan Xuehong met representatives from some departments of Hammersmith Hospital affiliated with Imperial College London, including Anesthesiology Department, Cardiac Surgery Department, and Health Care Division, and expressed their thanks for multiple training sessions provided by the hospital for the medical team of West China Hospital.

On July 14, the delegation met Ms. Betty Yue, supervisor of Continuing Education & Training Center of Imperial College London, and Professor Desmond Johnston, vice president of Medicine School. Both parties achieved deeper understanding of each other, which laid a solid foundation for future cooperation.

This visit to University of Liverpool, Cambridge University Hospitals, and Imperial College London improved mutual understanding between West China Hospital and advanced academic research institutes in UK, and was concluded with preliminary cooperation plans regarding medical education and research. Such cooperation will enable West China Hospital to better build an international brand and integrate international resources, thus greatly promoting internationalization process of West China Hospital.

View original content with multimedia:http://www.prnewswire.com/news-releases/a-delegation-led-by-director-li-weimin-of-west-china-hospital-sichuan-university-visited-the-uk-300498107.html

SOURCE West China Hospital of Sichuan University

See the original post:
A Delegation led by Director Li Weimin of West China Hospital, Sichuan University Visited the UK - Markets Insider

CIO – The C Suite

By Bianca Allery, Communications Manager, 3CXTechnology & InnovationPublished: 1 August 2017

When implementing new technologies, such as a Unified Communications solution, the main concern used to be the underlying infrastructure. However, far more attention is now being paid to the applications themselves instead of the network that underpins tem. This is due to the growth of the cloud, after all why worry about the infrastructure underpinning services when they are being hosted by another business many miles away? Yet even with in-house services, the shift in attention is noticeable.

However, this new way of looking at IT management underlines the many challenges issues that have been tied up in background infrastructure. Companies now expect that any new applications they introduce will be implemented quickly, easily and at a low cost. Yet as CIOs well know, it isnt always that simple. Applications and solutions may have very particular software and hardware demands, from installing the correct hardware PBX, to running software on the right operating system. As the role of the CIO evolves, they no longer have time to manage every detail of IT infrastructure. Instead, they just need to know that software works, whether on the cloud or for part of the 90% of desktop users still reliant on Windows.

Back to the futureHistorically, when organisations have invested in new technology, it has traditionally been brought in alongside its own software. While the software would ideally be fine-tuned for its purpose, it would also have its own demands, such as the need to run on a specific operating system.

Understandably, this caused major headaches for organisations, as they needed to maintain multiple operating systems, all of which are deemed necessary because of the add-on programmes they support. This strategy was both expensive, due to the cost of purchasing and managing these systems, and insecure because of the gaps created when systems are not updated regularly; particularly when developers stop providing security updates for legacy systems.

The advent of cloud has fuelled the ongoing simplification of IT infrastructure. After all, if the organisation can access software on-demand, it no longer needs to worry about the underlying infrastructure. At the same time, there is a growing expectation that applications will work on any operating system, so that a business can access Unified Communications whether it runs Windows, iOS, Linux or even a combination of all three mixture of the three and then some.

Nine to fiveAlong with this change in expectations has come a change in the CIOs role. At one point, CIOs were predominantly concerned with infrastructure and day-to-day IT operations, however modern CIOs now command a more strategic role leading the direction of IT in support of wider business strategy, rather than just focusing on the tech. In this environment, the applications become critical. For example, if an organisation seeks to target expansion in Latin America, it will want to know if its CRM and communication applications can support local languages. It will be less worried about what server and OS those applications sit on. The more time CIOs can spend thinking about how technology supports these strategic initiatives, rather than thinking about what is happening under the hood, the more effective they will be.

One of the simplest ways for CIOs to do this, is by adopting a software agnostic approach. Companies need to be able to add the necessary applications to the operating system used on any desktop, laptop or mobile, without limitation. Software agnosticism will ensure that CIOs can create a simplified, forward-looking and productive environment, which will be able to develop alongside the technical IT changes the future will present. The CIOs that grasp this concept, and adopt this approach to simplify their business for the future, will ultimately be the ones who are successful in the long run.

For more information please visit http://www.3cx.com

Read more here:
CIO - The C Suite